10-K.Info (Beta Test) Courtesy of Short Sands, LLC | ||||||||||||||
| ||||||||||||||
|
10-K.Info (Beta Test) Courtesy of Short Sands, LLC | |||
AMGEN INC | |||
Ticker: AMGN Fiscal Year: 2012 | |||
Consolidated Statements of Income | |||
Period Ending Dec 31, 2012 10-K (Filed: Feb 27, 2013) | |||
| (In Millions) | |||
| 12 Months Ended | 12 Months Ended | 12 Months Ended | |
| Dec 31, 2012 | Dec 31, 2011 | Dec 31, 2010 | |
| Revenues: | |||
| Product sales | $ 16,639 | 15,295 | 14,660 |
| Other revenues | 626 | 287 | 393 |
| Total revenues | 17,265 | 15,582 | 15,053 |
| Operating expenses: | |||
| Cost of sales (excludes amortization of certain acquired intangible assets presented separately) | 2,918 | 2,427 | 2,220 |
| Research and development | 3,380 | 3,167 | 2,894 |
| Selling, general and administrative | 4,801 | 4,486 | 3,983 |
| Amortization of certain acquired intangible assets | 294 | 294 | 294 |
| Other | 295 | 896 | 117 |
| Total operating expenses | 11,688 | 11,270 | 9,508 |
| Operating income | 5,577 | 4,312 | 5,545 |
| Interest expense, net | 1,053 | 610 | 604 |
| Interest and other income, net | 485 | 448 | 376 |
| Income before income taxes | 5,009 | 4,150 | 5,317 |
| Provision for income taxes | 664 | 467 | 690 |
| Net income | 4,345 | 3,683 | 4,627 |
| Earnings per share: | |||
| Basic | 5.61 | 4.07 | 4.82 |
| Diluted | 5.52 | 4.04 | 4.79 |
| Shares used in calculation of earnings per share: | |||
| Basic | 775 | 905 | 960 |
| Diluted | 787 | 912 | 965 |
10-K.Info (Beta Test) Courtesy of Short Sands, LLC | |||
AMGEN INC | |||
Ticker: AMGN Fiscal Year: 2012 | |||
Consolidated Statements of Comprehensive Income | |||
Period Ending Dec 31, 2012 10-K (Filed: Feb 27, 2013) | |||
| (In Millions, except shares in actual) | |||
| 12 Months Ended | 12 Months Ended | 12 Months Ended | |
| Dec 31, 2012 | Dec 31, 2011 | Dec 31, 2010 | |
| Net income | $ 4,345 | 3,683 | 4,627 |
| Other comprehensive income (loss), net of reclassification adjustments and taxes: | |||
| Foreign currency translation losses | (9) | (1) | (18) |
| Gains (losses) on the effective portion of cash flow hedges | (78) | 40 | 85 |
| Net unrealized gains (losses) on available-for-sale securities | 63 | (15) | 40 |
| Other gains (losses) | (1) | (6) | 1 |
| Other comprehensive income (loss), net of tax | (25) | 18 | 108 |
| Comprehensive income | 4,320 | 3,701 | 4,735 |
10-K.Info (Beta Test) Courtesy of Short Sands, LLC | |||
AMGEN INC | |||
Ticker: AMGN Fiscal Year: 2012 | |||
Consolidated Statements of Cash Flows | |||
Period Ending Dec 31, 2012 10-K (Filed: Feb 27, 2013) | |||
| (In Millions, except shares in actual) | |||
| 12 Months Ended | 12 Months Ended | 12 Months Ended | |
| Dec 31, 2012 | Dec 31, 2011 | Dec 31, 2010 | |
| Cash flows from operating activities: | |||
| Net income | $ 4,345 | 3,683 | 4,627 |
| Depreciation and amortization | 1,088 | 1,060 | 1,017 |
| Stock-based compensation expense | 362 | 341 | 353 |
| Deferred income taxes | 28 | (328) | (151) |
| Property, plant and equipment impairments | 178 | 6 | 118 |
| Other items, net | (74) | 63 | 140 |
| Changes in operating assets and liabilities, net of acquisitions: | |||
| Trade receivables, net | 348 | (557) | (210) |
| Inventories | (150) | (383) | 153 |
| Other assets | 124 | (204) | 20 |
| Accounts payable | 161 | (95) | 142 |
| Accrued income taxes | 87 | (20) | (656) |
| Legal reserve | (780) | 780 | 0 |
| Other liabilities | 165 | 773 | 234 |
| Net cash provided by operating activities | 5,882 | 5,119 | 5,787 |
| Cash flows from investing activities: | |||
| Purchases of property, plant and equipment | (689) | (567) | (580) |
| Cash paid for acquisitions, net of cash acquired | (2,390) | (701) | 0 |
| Purchases of marketable securities | (26,241) | (21,183) | (14,602) |
| Proceeds from sales of marketable securities | 17,372 | 20,871 | 10,485 |
| Proceeds from maturities of marketable securities | 1,994 | 749 | 642 |
| Other | (36) | 45 | (97) |
| Net cash used in investing activities | (9,990) | (786) | (4,152) |
| Cash flows from financing activities: | |||
| Net proceeds from issuance of debt | 4,933 | 10,387 | 2,471 |
| Repayment of debt | (123) | (2,500) | 0 |
| Net proceeds from issuance of commercial paper | 0 | 762 | 0 |
| Repayments of commercial paper | 0 | (762) | 0 |
| Repurchases of common stock | (4,607) | (8,315) | (3,786) |
| Dividends paid | (1,118) | (500) | 0 |
| Net proceeds from issuance of common stock in connection with the Company's equity award programs | 1,288 | 242 | 80 |
| Other | 46 | 12 | 3 |
| Net cash provided by (used in) financing activities | 419 | (674) | (1,232) |
| Increase (decrease) in cash and cash equivalents | (3,689) | 3,659 | 403 |
| Cash and cash equivalents at beginning of period | 6,946 | 3,287 | |
| Cash and cash equivalents at end of period | 3,257 | 6,946 | 3,287 |
10-K.Info (Beta Test) Courtesy of Short Sands, LLC | ||
AMGEN INC | ||
Ticker: AMGN Fiscal Year: 2012 | ||
Consolidated Balance Sheets | ||
Period Ending Dec 31, 2012 10-K (Filed: Feb 27, 2013) | ||
| (In Millions, except shares in actual) | ||
| As of | As of | |
| Dec 31, 2012 | Dec 31, 2011 | |
| ASSETS | ||
| Current assets: | ||
| Cash and cash equivalents | $ 3,257 | 6,946 |
| Marketable securities | 20,804 | 13,695 |
| Trade receivables, net | 2,518 | 2,896 |
| Inventories | 2,744 | 2,484 |
| Other current assets | 1,886 | 1,572 |
| Total current assets | 31,209 | 27,593 |
| Property, plant and equipment, net | 5,326 | 5,420 |
| Intangible assets, net | 3,968 | 2,584 |
| Goodwill | 12,662 | 11,750 |
| Other assets | 1,133 | 1,524 |
| Total assets | 54,298 | 48,871 |
| LIABILITIES AND STOCKHOLDERS' EQUITY | ||
| Current liabilities: | ||
| Accounts payable | 905 | 642 |
| Accrued liabilities | 4,791 | 5,028 |
| Current portion of long-term debt | 2,495 | 84 |
| Total current liabilities | 8,191 | 5,754 |
| Long-term debt | 24,034 | 21,344 |
| Other noncurrent liabilities | 3,013 | 2,744 |
| Contingencies and commitments | ||
| Stockholders' equity: | ||
| Common stock and additional paid-in capital; $0.0001 par value; 2,750.0 shares authorized; outstanding 756.3 shares in 2012 and 795.6 shares in 2011 | 29,337 | 27,777 |
| Accumulated deficit | (10,423) | (8,919) |
| Accumulated other comprehensive income | 146 | 171 |
| Total stockholders' equity | 19,060 | 19,029 |
| Total liabilities and stockholders' equity | 54,298 | 48,871 |
| External Links | |
| AMGEN INC (AMGN) Fiscal Year 2012 | |
| Statements of 10-K in Excel | https://www.sec.gov/.../Financial.xlxs |
| Complete 10-K in HTML | https://www.sec.gov/.../10-K.html |
| Complete 10-K in XBRL | https://www.sec.gov/.../10-K-xbrl.zip |